首页> 外文期刊>Hepatitis Monthly >The Effect of HBV Genotype C on the Development of HCC Differs Between Wild-Type Viruses and Those With BCP Double Mutations (T 1762 A 1764 )
【24h】

The Effect of HBV Genotype C on the Development of HCC Differs Between Wild-Type Viruses and Those With BCP Double Mutations (T 1762 A 1764 )

机译:HBV C基因型对野生型病毒和具有BCP双重突变的病毒之间的HCC差异的影响(T 1762 A 1764)

获取原文
       

摘要

Background: Association of hepatitis B virus (HBV) genotype C with hepatocellular carcinoma (HCC) development remains controversial. HBV basal core promoter (BCP) double mutations (T1762A1764) are very strong confounding factors of genotypes B and C in HCC development. Objectives: To investigate the association of HBV genotype C with HCC development after controlling for BCP double mutations. Materials and methods: Four hundred and two serum samples from patients with HCC, liver cirrhosis (LC) and chronic hepatitis (CH) and also from asymptomatic HBsAg carriers were analyzed. Results: Genotypes B (31.1%), C (62.8%), and I (6.1%) were detected. With the severity of liver disease the prevalence of genotype B decreased, but genotype C increased. No trend was found for genotype I. The prevalence of BCP double mutations in genotypes C and I viruses was significantly higher than genotype B. BCP double mutations are risk factors for CH, LC and HCC. Genotype C was not identified as a particular risk factor for HCC prior to the stratification analysis but after that genotype C viruses with BCP double mutations were found to be a particular risk factor for HCC (P = 0.008, OR = 17.19 [95% CI: 2.10 - 140.41]), but those with the wild-type BCP were not. In the interaction analysis, genotype C and BCP double mutations were found to have a synergistic effect on HCC development (P < 0.0001, OR = 52.56 [95% CI: 11.49-240.52]). Conclusions: The effect of HBV genotype C on the development of HCC differs between wild-type viruses and those with BCP double mutations, suggesting that not all individuals infected with genotype C HBV are at increased risk of HCC.
机译:背景:乙型肝炎病毒(HBV)基因型C与肝细胞癌(HCC)的发展仍存在争议。 HBV基底核心启动子(BCP)双突变(T 1762 A 1764 )是基因型B和C在肝癌发生过程中的强烈混杂因子。目的:探讨控制BCP双突变后HBV基因型C与肝癌发生的关系。材料和方法:分析了HCC,肝硬化(LC)和慢性肝炎(CH)患者以及无症状HBsAg携带者的420份血清样品。结果:检测到基因型B(31.1%),C(62.8%)和I(6.1%)。随着肝脏疾病的严重程度,基因型B的患病率降低,但基因型C的患病率增加。没有发现基因型I的趋势。基因型C和I病毒中BCP双重突变的患病率明显高于基因型B。BCP双重突变是CH,LC和HCC的危险因素。在分层分析之前,没有将C基因型确定为HCC的特定危险因素,但在此之后,发现具有BCP双突变的C基因型病毒是HCC的特定危险因素(P = 0.008,OR = 17.19 [95%CI: 2.10-140.41]),但那些野生型BCP则没有。在相互作用分析中,发现基因型C和BCP双重突变对HCC的发展具有协同作用(P <0.0001,OR = 52.56 [95%CI:11.49-240.52])。结论:在野生型病毒和具有BCP双重突变的病毒之间,C基因型HBV对HCC的影响有所不同,这表明并非所有感染C基因型HBV的人都具有更高的HCC风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号